Abstract
In cardiology and oncology, early disease detection produces better patient outcomes. Imaging approaches, particularly Magnetic Resonance Imaging (MRI), are attractive for screening large, mostly disease-free populations because they are noninvasive and produce high-resolution anatomical/morphological images from disease sites. Biochemically targeted nanoparticulate contrast agents (ultrasmall superparamagnetic iron oxide particles called USPIOs, superparamagnetic iron oxide nanoparticles called SPIONs, cross-linked iron oxides called CLIOs, Gadolinium chelates, and other superparamagnetic or paramagnetic particles) can be administered parenterally to define lesional biochemical/cellular composition, in addition to giving excellent definition of morphological features. Such targeted contrast agents can be considered modular nanobiological devices containing, at minimum, a contrast module and a targeting moiety. Here we review synthesis, surface chemistry and physics of superparamagnetic iron oxide MRI contrast agents (USPIOs and SPIONs) and results to date from the use of biochemically targeted and untargeted iron oxide MRI contrast agents in vivo, in vitro and ex vivo in vascular disease, and to a lesser extent, in oncology applications. We discuss design parameters critical to in vivo use of targeted contrast particles, including parameters influencing particle biodistribution/pharmacokinetics and immunogenicity. We discuss the increasing sophistication of theranostic contrast agents that provide other physiological services concurrent with their MRI function.
Keywords: Atherosclerosis, superparamagnetic nanoparticles, MRI, molecular imaging, vulnerable plaque, contrast agents
Current Nanoscience
Title: Nanoparticulate Iron Oxide Contrast Agents for Untargeted and Targeted Cardiovascular Magnetic Resonance Imaging
Volume: 5 Issue: 1
Author(s): A. Jasper Nijdam, Theodore R. Nicholson III, John P. Shapiro, Bryan R. Smith, Johannes T. Heverhagen, Petra Schmalbrock, Michael V. Knopp, Andrew Kebbel, David Wang and Stephen C. Lee
Affiliation:
Keywords: Atherosclerosis, superparamagnetic nanoparticles, MRI, molecular imaging, vulnerable plaque, contrast agents
Abstract: In cardiology and oncology, early disease detection produces better patient outcomes. Imaging approaches, particularly Magnetic Resonance Imaging (MRI), are attractive for screening large, mostly disease-free populations because they are noninvasive and produce high-resolution anatomical/morphological images from disease sites. Biochemically targeted nanoparticulate contrast agents (ultrasmall superparamagnetic iron oxide particles called USPIOs, superparamagnetic iron oxide nanoparticles called SPIONs, cross-linked iron oxides called CLIOs, Gadolinium chelates, and other superparamagnetic or paramagnetic particles) can be administered parenterally to define lesional biochemical/cellular composition, in addition to giving excellent definition of morphological features. Such targeted contrast agents can be considered modular nanobiological devices containing, at minimum, a contrast module and a targeting moiety. Here we review synthesis, surface chemistry and physics of superparamagnetic iron oxide MRI contrast agents (USPIOs and SPIONs) and results to date from the use of biochemically targeted and untargeted iron oxide MRI contrast agents in vivo, in vitro and ex vivo in vascular disease, and to a lesser extent, in oncology applications. We discuss design parameters critical to in vivo use of targeted contrast particles, including parameters influencing particle biodistribution/pharmacokinetics and immunogenicity. We discuss the increasing sophistication of theranostic contrast agents that provide other physiological services concurrent with their MRI function.
Export Options
About this article
Cite this article as:
Nijdam Jasper A., Nicholson III R. Theodore, Shapiro P. John, Smith R. Bryan, Heverhagen T. Johannes, Schmalbrock Petra, Knopp V. Michael, Kebbel Andrew, Wang David and Lee C. Stephen, Nanoparticulate Iron Oxide Contrast Agents for Untargeted and Targeted Cardiovascular Magnetic Resonance Imaging, Current Nanoscience 2009; 5 (1) . https://dx.doi.org/10.2174/157341309787314601
DOI https://dx.doi.org/10.2174/157341309787314601 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Safety and Efficacy of Aliskiren in the Treatment of Hypertension and Associated Clinical Conditions
Current Drug Safety Pharmacologic Modulators of Soluble Guanylate Cyclase/Cyclic Guanosine Monophosphate in the Vascular System - From Bench Top to Bedside
Current Vascular Pharmacology Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
Current Vascular Pharmacology Nonviral Gene Therapy and its Delivery Systems
Current Pharmaceutical Biotechnology Salvianolic Acid A Attenuates Cell Apoptosis, Oxidative Stress, Akt and NF-κB Activation in Angiotensin-II Induced Murine Peritoneal Macrophages
Current Pharmaceutical Biotechnology Patients with Prehypertension - Do we have Enough Evidence to Treat them?
Current Vascular Pharmacology Management of Hypertension-Journey from Single Drug Therapy to Multitargeted Ligand Therapy: A Clinical Overview
Current Clinical Pharmacology Human Platelets Express Authentic CB1 and CB2 Receptors
Current Neurovascular Research Emerging Role of microRNA in Neuropathic Pain
Current Drug Metabolism Vascular Biomarkers in Asthma and COPD
Current Topics in Medicinal Chemistry The Role of Trophoblast Nutrient and Ion Transporters in the Development of Pregnancy Complications and Adult Disease
Current Vascular Pharmacology How to Achieve Near Zero Fluoroscopy During Radiofrequency Ablation of Atrial Fibrillation: A Strategy Used at Two Centers
Current Cardiology Reviews Anticoagulation in Patients with Heparin-Induced Thrombocytopenia undergoing Percutaneous Coronary Angiography and Interventions
Current Pharmaceutical Design In the Search of the Vulnerable Plaque: Current Diagnostic Techniques and Future Directions
Vascular Disease Prevention (Discontinued) Adonis sp., Convallaria sp., Strophanthus sp., Thevetia sp., and Leonurus sp. - Cardiotonic Plants with Known Traditional Use and a Few Preclinical and Clinical Studies
Current Pharmaceutical Design Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection
Current Drug Metabolism Peroxynitrite-Driven Mechanisms in Diabetes and Insulin Resistance – the Latest Advances
Current Medicinal Chemistry MRI Contrast Agents: Current Status and Future Perspectives
Anti-Cancer Agents in Medicinal Chemistry Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Beta-Blockers in the Treatment of Dilated Cardiomyopathy: Which is the Best?
Current Pharmaceutical Design